Potential plasma biomarkers for progression of knee osteoarthritis using glycoproteomic analysis coupled with a 2D-LC-MALDI system
Authors:
- Isao FukudaIFIsao Fukuda
- Takeshi IshiharaTITakeshi Ishihara
- Shigeki OhmachiSOShigeki Ohmachi
- Ikue SakikawaISIkue Sakikawa
- Atsushi MoritaAMAtsushi Morita
- Minoru IkedaMIMinoru Ikeda
- Shoji YamaneSYShoji Yamane
- Tomoko Toyosaki-MaedaTTTomoko Toyosaki-Maeda
- Yoshihiko TakinamiYTYoshihiko Takinami
- Hiroyuki OkamotoHOHiroyuki Okamoto
- Yoshito NumataYNYoshito Numata
- Naoshi FukuiNFNaoshi Fukui
Open Access
- 6 June 2012
- journal article
- research article
- Published by Springer Nature in Proteome Science
- Vol. 10 (1) , 36
Abstract
Background: Although osteoarthritis (OA) is a highly prevalent joint disease, to date, no reliable biomarkers have been found for the disease. In this study, we attempted to identify factors the amounts of which significantly change in association with the progression of knee OA.Methods: A total of 68 subjects with primary knee OA were enrolled in the study. These subjects were followed up over an 18-month period, and plasma and serum samples were obtained together with knee radiographs every 6 months, i.e., 0, 6, 12 and 18 months after the enrollment. Progressors and non-progressors were determined from the changes on radiographs, and plasma samples from those subjects were subjected toN-glycoproteomic 2D-LC-MALDI analysis. MS peaks were identified, and intensities for respective peaks were compared between the progressors and non-progressors to find the peak intensities of which differed significantly between the two groups of subjects. Proteins represented by the chosen peaks were identified by MS/MS analysis. Expression of the identified proteins was evaluated in synovial tissues from 10 OA knee joints byin situhybridization, western blotting analysis and ELISA.Results: Among the subjects involved in the study, 3 subjects were determined to be progressors, and 6 plasma and serum samples from these subjects were subjected to the analysis together with another 6 samples from the non-progressors. More than 3000 MS peaks were identified byN-glycoproteomic 2D-LC-MALDI analysis. Among them, 4 peaks were found to have significantly different peak intensities between the progressors and non-progressors. MS/MS analysis revealed that these peaks represented clusterin, hemopexin, alpha-1 acid glycoprotein-2, and macrophage stimulating protein, respectively. The expression of these genes in OA synovium was confirmed byin situhybridization, and for clusterin and hemopexin, by western blotting analysis and ELISA as well.Conclusions: In this study, 4 potential biomarkers were identified as potential prognostic markers for knee OA throughN-glycoproteomic analysis. To the best of our knowledge, this is the first report for the use of glycoproteomic technology in exploring potential biomarkers for knee OA.Keywords
This publication has 47 references indexed in Scilit:
- Proteomics role in the search for improved diagnosis, prognosis and treatment of osteoarthritisOsteoarthritis and Cartilage, 2010
- Lifetime risk of symptomatic knee osteoarthritisArthritis Care & Research, 2008
- Changes in surgical loads and economic burden of hip and knee replacements in the US: 1997–2004Arthritis Care & Research, 2008
- The burden of musculoskeletal disease—a global perspectiveClinical Rheumatology, 2006
- Review: Collagen markers in early arthritic diseasesClinica Chimica Acta, 2006
- Pathogenesis and management of pain in osteoarthritisThe Lancet, 2005
- Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five yearsArthritis & Rheumatism, 2004
- Perspectives on the future of bone and joint diseases.2003
- The Human Plasma ProteomeMolecular & Cellular Proteomics, 2002
- Radiological progression of osteoarthritis: an 11 year follow up study of the knee.Annals of the Rheumatic Diseases, 1992